Ascensia Inks Distribution Deal To Enter CGM Market
Executive Summary
Ascensia Diabetes Care plans to start selling its first continuous glucose monitoring devices this year based on a distribution deal with Zhejiang POCTech Co. Ltd, announced Jan. 7 at the JP Morgan Healthcare Conference. The partnership will also include product development.
You may also be interested in...
Roche Wins FDA Breakthrough Device Designation For Alzheimer’s Test
Roche announced on 11 April it received FDA breakthrough device designation for a blood test used for early detection of Alzheimer’s disease.
Orthobond, Onkos Surgical Receive FDA De Novo Approval For Antibacterial Technology Used In Medical Devices
Technology partners, Orthobond and Onkos Surgical, announced they received FDA de novo approval for their respective technologies to actively kill bacteria that could contaminate medical devices.
News We’re Watching: Lung Preservation System Goes National, De Novo For MMI, Brazil’s ANVISA To Recognize Overseas Approvals
This week, Paragonix announced that its BAROguard lung preservation system is now available throughout the US; Brazil planned to leverage some foreign device approvals; Medical Microinstruments’ Symani Surgical System won de novo clearance; and the FDA updated its safety warnings for Essure and certain plastic syringes.